Leptin and lipid metabolism in chronic kidney failure

References

• Beltowski J. Leptin and atherosclerosis. Atherosclerosis 2006; 189: 47–60
   PubMed Web of Science ®Google Scholar
• Peelman F., Waelput W., Iserentant H., Lavens D., Eyckerman S., Zabeau L., Tavernier J. Leptin: linking adipocyte metabolism with cardiovascular and autoimmune diseases. Prog Lipid Res 2004; 43: 283–301
   PubMed Web of Science ®Google Scholar
• Iribarren C., Husson G., Go A. S., Lo J. C., Fair J. M., Rubin G. D., Hlatky M. A., Fortmann S. P. Plasma leptin levels and coronary artery calcification in older adults. J Clin Endocrinol Metab 2007; 92: 729–32
   PubMed Web of Science ®Google Scholar
• Wallace A. M., McMahon A. D., Packard C. J., Kelly A., Shepherd J., Gaw A., Sattar N. Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 2001; 104: 3052–6
   PubMed Web of Science ®Google Scholar
• Couillard C., Lamarche B., Mauriège P., Cantin B., Dagenais G. R., Moorjani S., Lupien P‐J., Després J‐P. Leptinemia is not a risk factor for ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Diabetes Care 1998; 21: 782–6
   PubMed Web of Science ®Google Scholar
• Wannamethee S. G., Tchernova J., Whincup P., Lowe G. D. O., Kelly A., Rumley A., Wallace A. M., Sattar N. Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis 2007; 191: 418–26
   PubMed Web of Science ®Google Scholar
• Barba G., Russo O., Siani A., Iacone R., Farinaro E., Gerardi M. C., Russo P., Della Valle E., Strazzullo P. Plasma leptin and blood pressure in men: graded association independent of body mass and fat pattern. Obes Res 2003; 11: 160–6
   PubMedGoogle Scholar
• Oral E. A., Simha V., Ruiz E., Andewelt A., Premkumar A., Snell P., Wagner A. J., DePaoli A. M., Reitman M. L., Taylor S. I., Gorden P., Garg A. Leptin‐replacement therapy for lipodystrophy. N Engl J Med 2002; 346: 570–8
   PubMed Web of Science ®Google Scholar
• Havel P. J. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 2004; 53(Suppl 1)S143–51
   PubMed Web of Science ®Google Scholar
• Sharma K., Considine R. V., Michael B., Dunn S. R., Weisberg L. S., Kurnik B. R. C., Kurnik P. B., O'Connor J., Sinha M., Caro J. F. Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int 1997; 51: 1980–5
   PubMed Web of Science ®Google Scholar
• Dagogo‐Jack S., Ovalle F., Landt M., Gearing B., Coyne D. W. Hyperleptinemia in patients with end‐stage renal disease undergoing continuous ambulatory peritoneal dialysis. Perit Dial Int 1998; 18: 34–40
   PubMed Web of Science ®Google Scholar
• Heimbürger O., Lönnqvist F., Danielsson A., Nordenström J., Stenvinkel P. Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol 1997; 8: 1423–30
   PubMed Web of Science ®Google Scholar
• Nordfors L., Lönnqvist F., Heimbürger O., Danielsson A., Schalling M., Stenvinkel P. Low leptin gene expression and hyperleptinemia in chronic renal failure. Kidney Int 1998; 54: 1267–75
   PubMed Web of Science ®Google Scholar
• Foley R. N., Parfrey P. S., Sarnak M. J. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32: S112–19
   PubMed Web of Science ®Google Scholar
• Aguilera A., Bajo M. A., Rebollo F., Díez J. J., Dìaz C., Paiva A., Codoceo R., Selgas R. Leptin as a marker of nutrition and cardiovascular risk in peritoneal dialysis patients. Adv Perit Dial 2002; 18: 212–17
   PubMedGoogle Scholar
• Nakazono H., Nagake Y., Ichikawa H., Makino H. Serum leptin concentrations in patients on hemodialysis. Nephron 1998; 80: 35–40
   PubMed Web of Science ®Google Scholar
• Rodríguez‐Carmona A., Pérez Fontán M., Cordido F., García Falcón T., García‐Buela J. Hyperleptinemia is not correlated with markers of protein malnutrition in chronic renal failure. A cross‐sectional study in predialysis, peritoneal dialysis and hemodialysis patients. Nephron 2000; 86: 274–80
   PubMed Web of Science ®Google Scholar
• Huttunen K., Huttunen N. P., Koivula A., Ahonen A., Puukka R. 99mTc‐DTPA – a useful clinical tool for the measurement of glomerular filtration rate. Scand J Urol Nephrol 1982; 16: 237–41
   PubMed Web of Science ®Google Scholar
• Rantala A. O., Kauma H., Lilja M., Savolainen M. J., Reunanen A., Kesäniemi Y. A. Prevalence of the metabolic syndrome in drug‐treated hypertensive patients and control subjects. J Intern Med 1999; 245: 163–74
   PubMed Web of Science ®Google Scholar
• Levey A. S., Coresh J., Balk E., Kausz A. T., Levin A., Steffes M. W., Hogg R. J., Perrone R. D., Lau J., Eknoyan G. National Kidney Foundation Practice Guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137–47
   PubMed Web of Science ®Google Scholar
• Havel R. J., Eder H. A., Bragdon J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34: 1345–53
   PubMed Web of Science ®Google Scholar
• Lipid Research Clinics Program. Manual of laboratory operations. Lipid and lipoprotein analysis. DHEW publications (NIH), Bethesda 1974; 56–7
   Google Scholar
• Menon V., Wang X., Greene T., Beck G. J., Kusek J. W., Marcovina S. M., Levey A. S., Sarnak M. J. Factors associated with serum leptin in patients with chronic kidney disease. Clin Nephrol 2004; 61: 163–9
   PubMed Web of Science ®Google Scholar
• Sarnak M. J., Poindexter A., Wang S. R., Beck G. J., Kusek J. W., Marcovina S. M., Greene T., Levey A. S. Serum C‐reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study. Kidney Int 2002; 62: 2208–15
   PubMed Web of Science ®Google Scholar
• Pérez Fontán M., Rodríguez‐Carmona A., Cordido F., García‐Buela J. Hyperleptinemia in uremic patients undergoing conservative management, peritoneal dialysis, and hemodialysis: a comparative analysis. Am J Kidney Dis 1999; 34: 824–31
   PubMed Web of Science ®Google Scholar
• Ostlund R. E., Jr, Yang J. W., Klein S., Gingerich R. Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab 1996; 81: 3909–13
   PubMed Web of Science ®Google Scholar
• Chan D. C., Watts G. F., Ng T. W., Uchida Y., Sakai N., Yamashita S., Barrett P. H. R. Adiponectin and other adipocytokines as predictors of markers of triglyceride‐rich lipoprotein metabolism. Clin Chem 2005; 51: 578–85
   PubMed Web of Science ®Google Scholar
• Nagao K., Inoue N., Ujino Y., Higa K., Shirouchi B., Wang Y. M., Yanagita T. Effect of leptin infusion on insulin sensitivity and lipid metabolism in diet‐induced lipodystrophy model mice. Lipids Health Dis 2008; 7: 8–15
   PubMed Web of Science ®Google Scholar
• Liao W., Angelin B., Rudling M. Lipoprotein metabolism in the fat Zucker rat: reduced basal expression but normal regulation of hepatic low density lipoprotein receptors. Endocrinology 1997; 138: 3276–82
   PubMed Web of Science ®Google Scholar
• Silver D. L., Jiang X., Tall A. R. Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA‐I and ApoA‐II, and decreased ApoA‐I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover. J Biol Chem 1999; 274: 4140–6
   PubMed Web of Science ®Google Scholar
• Matsuoka N., Ogawa Y., Masuzaki H., Ebihara K., Aizawa‐Abe M., Satoh N., Ishikawa E., Fujisawa Y., Kosaki A., Yamada K., Kuzuya H., Nakao K. Decreased triglyceride‐rich lipoproteins in transgenic skinny mice overexpressing leptin. Am J Physiol Endocrinol Metab 2001; 280: E334–9
   PubMed Web of Science ®Google Scholar
• Lundåsen T., Liao W., Angelin B., Rudling M. Leptin induces the hepatic high density lipoprotein receptor scavenger receptor B type I (SR‐BI) but not cholesterol 7α‐hydroxylase (Cyp7a1) in leptin‐deficient (ob/ob) mice. J Biol Chem 2003; 278: 43224–8
   PubMed Web of Science ®Google Scholar
• Kosztáczky B., Fóris G., Paragh G., Jr, Seres I., Zsiros E., Koncsos P., Balogh Z., Paragh G. Leptin stimulates endogenous cholesterol synthesis in human monocytes: new role of an old player in atherosclerotic plaque formation. Leptin induced increase in cholesterol synthesis. Int J Biochem Cell Biol 2007; 39: 1637–45
   PubMed Web of Science ®Google Scholar
• Hallikainen M., Kolehmainen M., Schwab U., Laaksonen D. E., Niskanen L., Rauramaa R., Pihlajamäki J., Uusitupa M., Miettinen T. A., Gylling H. Serum adipokines are associated with cholesterol metabolism in the metabolic syndrome. Clin Chim Acta 2007; 383: 126–32
   PubMed Web of Science ®Google Scholar
• Ukkola O., Kesäniemi Y. A. Leptin and high‐sensitivity C‐reactive protein and their interaction in the metabolic syndrome in middle‐aged subjects. Metabolism 2007; 56: 1221–7
   PubMed Web of Science ®Google Scholar
• Díez J. J., Iglesias P., Fernández‐Reyes M. J., Aguilera A., Bajo M. A., Alvarez‐Fidalgo P., Codoceo R., Selgas R. Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end‐stage renal disease. Clin Endocrinol (Oxf) 2005; 62: 242–9
   PubMed Web of Science ®Google Scholar
• Stenvinkel P., Heimbürger O., Lönnqvist F. Serum leptin concentrations correlate to plasma insulin concentrations independent of body fat content in chronic renal failure. Nephrol Dial Transplant 1997; 12: 1321–5
   PubMed Web of Science ®Google Scholar